Clinical trial
Infliximab Proactive Drug Monitoring in the Pediatric IBD Population
NCT04921670 is registered in ClinicalTrials.gov with Cares, Kristen, M.D. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Infliximab Proactive Drug Monitoring in the Pediatric IBD Population
- Lead sponsor
- Cares, Kristen, M.D.
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 12, 2021
- Completion date
- August 30, 2025
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inflammatory bone disease